2-(4-chlorobenzoyl)-N-(3-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide

ID: ALA4860459

PubChem CID: 164616033

Max Phase: Preclinical

Molecular Formula: C24H21ClN2O3

Molecular Weight: 420.90

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(NC(=O)C2c3ccccc3CCN2C(=O)c2ccc(Cl)cc2)c1

Standard InChI:  InChI=1S/C24H21ClN2O3/c1-30-20-7-4-6-19(15-20)26-23(28)22-21-8-3-2-5-16(21)13-14-27(22)24(29)17-9-11-18(25)12-10-17/h2-12,15,22H,13-14H2,1H3,(H,26,28)

Standard InChI Key:  NEDXEVWIIDZOMK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    8.9010   -2.2122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8999   -3.0317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6079   -3.4407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6061   -1.8033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3147   -2.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3155   -3.0276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0240   -3.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7323   -3.0238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7276   -2.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0185   -1.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0257   -4.2518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3189   -4.6619    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7343   -4.6590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3206   -5.4791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6121   -5.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6134   -6.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3225   -7.1084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0317   -6.6939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0269   -5.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7417   -7.0986    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4416   -3.4297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4448   -4.2468    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1477   -3.0183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8542   -3.4286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5598   -3.0179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5571   -2.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8428   -1.7942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1401   -2.2072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2627   -1.7876    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   12.4471   -6.6860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
  7 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 18 20  1  0
  8 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 20 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4860459

    ---

Associated Targets(Human)

NUGC-3 (976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.90Molecular Weight (Monoisotopic): 420.1241AlogP: 4.73#Rotatable Bonds: 4
Polar Surface Area: 58.64Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.82CX Basic pKa: CX LogP: 4.61CX LogD: 4.61
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.66Np Likeness Score: -1.21

References

1. Sim S, Lee S, Ko S, Phuong Bui B, Linh Nguyen P, Cho J, Lee K, Kang JS, Jung JK, Lee H..  (2021)  Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.,  46  [PMID:34500188] [10.1016/j.bmc.2021.116371]

Source